Alegre, John Mark Y.
HRN: 28-69-98 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
CEFUROXIME 750MG (VIAL)
03/17/2026
03/24/2026
IV
420mg
Q8
AGE URTI
Checking Initial Appropriateness
03/20/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
03/20/2026
03/27/2026
IV
5ml
TID
Intestinal Amoebasis
Checking Initial Appropriateness